NEW YORK, Dec. 12, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of TerraVia Holdings, Inc. (NASDAQ:TVIA) between August 8, 2016 and November 7, 2016. You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Northern District of California. To get more information go to:
http://www.zlk.com/pslra/terravia-holdings
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that TerraVia made false and/or misleading statements and/or failed to disclose: (1) that the Company’s products caused gastrointestinal distress, such as nausea and vomiting; and (2) as a result, statements about TerraVia’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis at all relevant times.
On November 7, 2016, Bloomberg published an article alleging that an algal flour ingredient provided by TerraVia causes consumers to become sick, and that Rosa Foods will be removing the ingredient altogether from its product formulations by early 2017. When this information was released, shares of TerraVia declined in value, causing investors harm.
If you suffered a loss in TerraVia you have until January 17, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns 



